Literature DB >> 7529991

Effects of insertion of multiple AP-1 binding sites into the U3 region of the long terminal repeat of feline immunodeficiency virus.

T Miyazawa1, K Tomonaga, Y Kawaguchi, M Kohmoto, Y Inoshima, K Maeda, T Mikami, K ] Maedadel K [corrected to Maeda.   

Abstract

An oligonucleotide containing multiple AP-1 binding sites was introduced into the regulatory sequence in the long terminal repeat (LTR) of feline immunodeficiency virus (FIV). Chloramphenicol acetyltransferase assay revealed that basal promoter activity of the mutated LTR was higher than that of the wild-type LTR in Crandell feline kidney (CRFK) cells. The mutated LTR was introduced into an infectious molecular clone of FIV and the clone was transfected into CRFK cells. The virus production of the mutant in the cells was as high as that of the wild-type when determined by the reverse transcriptase activity assay. The growth of the mutant virus obtained from the transfected CRFK cells was examined in feline T lymphoblastoid cell lines (MYA-1 and FeL-039 cells) and primary feline peripheral blood mononuclear cells (fPBMCs). The growth was delayed when compared with that of the wild-type virus in all the cells used. Upon examination by polymerase chain reaction, the length of the LTR of the mutant virus was shortened in both MYA-1 cells and fPBMCs. Sequence analysis revealed that the insertion was completely deleted 39 days after infection in the MYA-1 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529991      PMCID: PMC7086681          DOI: 10.1007/bf01309453

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  30 in total

1.  Comparison of two host cell range variants of feline immunodeficiency virus.

Authors:  T R Phillips; R L Talbott; C Lamont; S Muir; K Lovelace; J H Elder
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

Review 2.  Regulatory pathways governing HIV-1 replication.

Authors:  B R Cullen; W C Greene
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

3.  Expression of feline infectious peritonitis coronavirus antigens on the surface of feline macrophage-like cells.

Authors:  H E Jacobse-Geels; M C Horzinek
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

4.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

5.  The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes.

Authors:  T Miyazawa; M Kohmoto; Y Kawaguchi; K Tomonaga; T Toyosaki; K Ikuta; A Adachi; T Mikami
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

6.  Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus.

Authors:  T R Phillips; C Lamont; D A Konings; B L Shacklett; C A Hamson; P A Luciw; J H Elder
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

7.  Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1.

Authors:  Y Kawaguchi; J Norimine; T Miyazawa; C Kai; T Mikami
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

8.  Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.

Authors:  E E Sparger; B L Shacklett; L Renshaw-Gegg; P A Barry; N C Pedersen; J H Elder; P A Luciw
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

9.  Growth properties of a feline immunodeficiency virus mutant which lacks an AP-1 binding site in primary peripheral blood mononuclear cells.

Authors:  T Miyazawa; Y Inoshima; M Kohmoto; Y Ikeda; T Mikami
Journal:  J Vet Med Sci       Date:  1994-10       Impact factor: 1.267

10.  Molecular characterization and heterogeneity of feline immunodeficiency virus isolates.

Authors:  N Maki; T Miyazawa; M Fukasawa; A Hasegawa; M Hayami; K Miki; T Mikami
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

View more
  2 in total

1.  CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells.

Authors:  E M Poeschla; D J Looney
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

2.  Genetic Evolution during the development of an attenuated EIAV vaccine.

Authors:  Xue-Feng Wang; Yue-Zhi Lin; Qiang Li; Qiang Liu; Wei-Wei Zhao; Cheng Du; Jie Chen; Xiaojun Wang; Jian-Hua Zhou
Journal:  Retrovirology       Date:  2016-02-03       Impact factor: 4.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.